rs496503

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_020822.3(KCNT1):​c.110+2760G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.868 in 152,252 control chromosomes in the GnomAD database, including 57,815 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.87 ( 57815 hom., cov: 33)

Consequence

KCNT1
NM_020822.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.41

Publications

5 publications found
Variant links:
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]
KCNT1 Gene-Disease associations (from GenCC):
  • childhood-onset epilepsy syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 14
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • autosomal dominant nocturnal frontal lobe epilepsy 5
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.92 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020822.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNT1
NM_020822.3
MANE Select
c.110+2760G>A
intron
N/ANP_065873.2Q5JUK3-3
KCNT1
NM_001272003.2
c.110+2760G>A
intron
N/ANP_001258932.1Q5JUK3-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNT1
ENST00000371757.7
TSL:1 MANE Select
c.110+2760G>A
intron
N/AENSP00000360822.2Q5JUK3-3
KCNT1
ENST00000460750.5
TSL:1
n.110+2760G>A
intron
N/AENSP00000418777.1F8WC49
KCNT1
ENST00000487664.5
TSL:5
c.110+2760G>A
intron
N/AENSP00000417851.2Q5JUK3-2

Frequencies

GnomAD3 genomes
AF:
0.868
AC:
132044
AN:
152132
Hom.:
57805
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.747
Gnomad AMI
AF:
0.978
Gnomad AMR
AF:
0.865
Gnomad ASJ
AF:
0.847
Gnomad EAS
AF:
0.836
Gnomad SAS
AF:
0.911
Gnomad FIN
AF:
0.966
Gnomad MID
AF:
0.830
Gnomad NFE
AF:
0.926
Gnomad OTH
AF:
0.861
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.868
AC:
132101
AN:
152252
Hom.:
57815
Cov.:
33
AF XY:
0.870
AC XY:
64790
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.747
AC:
30998
AN:
41512
American (AMR)
AF:
0.864
AC:
13223
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.847
AC:
2942
AN:
3472
East Asian (EAS)
AF:
0.836
AC:
4318
AN:
5166
South Asian (SAS)
AF:
0.911
AC:
4394
AN:
4824
European-Finnish (FIN)
AF:
0.966
AC:
10260
AN:
10618
Middle Eastern (MID)
AF:
0.832
AC:
243
AN:
292
European-Non Finnish (NFE)
AF:
0.926
AC:
63009
AN:
68036
Other (OTH)
AF:
0.861
AC:
1822
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
881
1763
2644
3526
4407
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
892
1784
2676
3568
4460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.902
Hom.:
186935
Bravo
AF:
0.852
Asia WGS
AF:
0.865
AC:
3010
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
0.39
DANN
Benign
0.45
PhyloP100
-2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs496503; hg19: chr9-138596974; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.